IT'S TIME TO SURPASS HUMAN MEDICINE Trademark

Trademark Overview


On Saturday, October 5, 2024, a trademark application was filed for IT'S TIME TO SURPASS HUMAN MEDICINE with the United States Patent and Trademark Office. The USPTO has given the IT'S TIME TO SURPASS HUMAN MEDICINE trademark a serial number of 98787114. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, April 9, 2025. The IT'S TIME TO SURPASS HUMAN MEDICINE trademark is filed in the Medical Instrument Products category with the following description:

Veterinary bio-technology device apparatus development and sale.

General Information


Serial Number98787114
Word MarkIT'S TIME TO SURPASS HUMAN MEDICINE
Filing DateSaturday, October 5, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, April 9, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkIT IS TIME TO SURPASS HUMAN MEDICINE
Goods and ServicesVeterinary bio-technology device apparatus development and sale.

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateSaturday, October 5, 2024
Primary Code010
First Use Anywhere DateSunday, August 20, 2023
First Use In Commerce DateSunday, August 20, 2023

Trademark Owner History


Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressConcord, NC 28025

Trademark Events


Event DateEvent Description
Saturday, October 5, 2024NEW APPLICATION ENTERED
Tuesday, April 8, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 9, 2025ASSIGNED TO EXAMINER
Wednesday, April 9, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 9, 2025NON-FINAL ACTION E-MAILED
Wednesday, April 9, 2025NON-FINAL ACTION WRITTEN